Saroglitazar Magnesium 4 mg for Nonalcoholic Fatty Liver Disease (NAFLD) in People Living With HIV in the US
Clinical trial NCT05211284 · TERMINATED
Trial details
- NCT number
- NCT05211284
- Sponsor
- Zydus Therapeutics Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-08
- Primary completion
- 2023-10-02
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.